Press releases
- Zimmer Biomet Announces Webcast and Conference Call of Second Quarter 2024 Financial Results
- Zimmer Biomet Announces Appointment of Devdatt Kurdikar to Board of Directors
- RevelAi Health and Zimmer Biomet Announce Exclusive Multi-Year Co-Marketing Agreement to Advance Value-Based Care and Health Equity through AI-Powered Technology
- Zimmer Biomet Enters Distribution Agreement with THINK Surgical to Offer TMINI® Miniature Handheld Robotic System for Total Knee Arthroplasty
- Zimmer Biomet to Present at the Goldman Sachs 45th Annual Healthcare Conference
- Zimmer Biomet Outlines Strategy to Deliver Above Market Growth at 2024 Investor Day
- Zimmer Biomet Announces 2024 Investor Day
- Zimmer Biomet Announces Quarterly Dividend for Second Quarter of 2024
- Zimmer Biomet Publishes 2023 Sustainability Report
- Zimmer Biomet Announces First Quarter 2024 Financial Results
More ▼
Key statistics
As of last trade Zimmer Biomet Holdings Inc (ZIM:FRA) traded at 101.00, 3.97% above its 52-week low of 97.14, set on Oct 13, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 101.00 |
---|---|
High | 101.00 |
Low | 101.00 |
Bid | 101.35 |
Offer | 101.85 |
Previous close | 101.85 |
Average volume | 353.88 |
---|---|
Shares outstanding | 205.73m |
Free float | 205.48m |
P/E (TTM) | 24.04 |
Market cap | 22.85bn USD |
EPS (TTM) | 4.62 USD |
Annual div (ADY) | 0.8988 EUR |
---|---|
Annual div yield (ADY) | 0.88% |
Div ex-date | Jun 26 2024 |
Div pay-date | Jul 31 2024 |
Data delayed at least 15 minutes, as of Jul 22 2024 07:10 BST.
More ▼